ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
Main Authors: | Reese, Jordan M, Suman, Vera J, Subramaniam, Malayannan, Wu, Xianglin, Negron, Vivian, Gingery, Anne, Pitel, Kevin S, Shah, Sejal S, Cunliffe, Heather E, McCullough, Ann E, Pockaj, Barbara A, Couch, Fergus J, Olson, Janet E, Reynolds, Carol, Lingle, Wilma L, Spelsberg, Thomas C, Goetz, Matthew P, Ingle, James N, Hawse, John R |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196114/ |
Similar Items
-
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
by: Wu, Xianglin, et al.
Published: (2011) -
Endoxifen’s Molecular Mechanisms of Action Are Concentration Dependent and Different than That of Other Anti-Estrogens
by: Hawse, John R., et al.
Published: (2013) -
The Effects of a Novel Hormonal Breast Cancer Therapy, Endoxifen, on the Mouse Skeleton
by: Gingery, Anne, et al.
Published: (2014) -
Aurora-A Mitotic Kinase Induces Endocrine Resistance through Down-Regulation of ERα Expression in Initially ERα+ Breast Cancer Cells
by: Opyrchal, Mateusz, et al.
Published: (2014) -
TGF-β Inducible Early Gene 1 Regulates Osteoclast Differentiation and Survival by Mediating the NFATc1, AKT, and MEK/ERK Signaling Pathways
by: Cicek, Muzaffer, et al.
Published: (2011)